{
    "organizations": [],
    "uuid": "a04cd990d831cf47cc656ef2e80e46f23ca77384",
    "author": "",
    "url": "https://www.reuters.com/article/brief-invivo-therapeutics-says-there-is/brief-invivo-therapeutics-says-there-is-substantial-doubt-about-ability-to-continue-as-a-going-concern-idUSFWN1PO0KR",
    "ord_in_thread": 0,
    "title": "BRIEF-Invivo Therapeutics Says There Is Substantial Doubt About Ability To Continue As A Going Concern",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "January 29, 2018 / 11:23 AM / in 9 minutes BRIEF-Invivo Therapeutics Says There Is Substantial Doubt About Ability To Continue As A Going Concern Reuters Staff 1 Min Read \nJan 29 (Reuters) - Invivo Therapeutics Holdings Corp : \n* INVIVO THERAPEUTICS SAYS “THERE IS SUBSTANTIAL DOUBT ABOUT OUR ABILITY TO CONTINUE AS A GOING CONCERN” - SEC FILING \n* INVIVO THERAPEUTICS - CURRENT CASH RESOURCES WILL NOT BE SUFFICIENT TO COMPLETE CLINICAL DEVELOPMENT OF NEURO-SPINAL SCAFFOLD IMPLANT Source text: ( bit.ly/2rOeCK6 ) Further company coverage:",
    "published": "2018-01-29T13:22:00.000+02:00",
    "crawled": "2018-01-29T13:47:04.027+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "january",
        "minute",
        "therapeutic",
        "say",
        "substantial",
        "doubt",
        "ability",
        "continue",
        "going",
        "concern",
        "reuters",
        "staff",
        "min",
        "read",
        "jan",
        "reuters",
        "invivo",
        "therapeutic",
        "holding",
        "corp",
        "invivo",
        "therapeutic",
        "say",
        "substantial",
        "doubt",
        "ability",
        "continue",
        "going",
        "concern",
        "sec",
        "filing",
        "invivo",
        "therapeutic",
        "current",
        "cash",
        "resource",
        "sufficient",
        "complete",
        "clinical",
        "development",
        "scaffold",
        "implant",
        "source",
        "text",
        "company",
        "coverage"
    ]
}